U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656688) titled 'Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease' on June 16.
Brief Summary: Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to severe dry eye disease.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease (DED)
Intervention:
DRUG: HUC1-394
ophthalmic solution. Participants will instill 1 drop in each eye
DRUG: Placebo
ophthalmic solution. Participants will instill 1 drop in each eye
Recruitment Status: RECRUITING
Sponsor: Huons Co., Ltd.
Published by ...